Correlation Between Unity Biotechnology and Recursion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Unity Biotechnology and Recursion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unity Biotechnology and Recursion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unity Biotechnology and Recursion Pharmaceuticals, you can compare the effects of market volatilities on Unity Biotechnology and Recursion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unity Biotechnology with a short position of Recursion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unity Biotechnology and Recursion Pharmaceuticals.
Diversification Opportunities for Unity Biotechnology and Recursion Pharmaceuticals
0.33 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Unity and Recursion is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Unity Biotechnology and Recursion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Recursion Pharmaceuticals and Unity Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unity Biotechnology are associated (or correlated) with Recursion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Recursion Pharmaceuticals has no effect on the direction of Unity Biotechnology i.e., Unity Biotechnology and Recursion Pharmaceuticals go up and down completely randomly.
Pair Corralation between Unity Biotechnology and Recursion Pharmaceuticals
Considering the 90-day investment horizon Unity Biotechnology is expected to under-perform the Recursion Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Unity Biotechnology is 1.39 times less risky than Recursion Pharmaceuticals. The stock trades about -0.22 of its potential returns per unit of risk. The Recursion Pharmaceuticals is currently generating about -0.12 of returns per unit of risk over similar time horizon. If you would invest 687.00 in Recursion Pharmaceuticals on August 28, 2024 and sell it today you would lose (87.00) from holding Recursion Pharmaceuticals or give up 12.66% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unity Biotechnology vs. Recursion Pharmaceuticals
Performance |
| Timeline |
| Unity Biotechnology |
| Recursion Pharmaceuticals |
Unity Biotechnology and Recursion Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unity Biotechnology and Recursion Pharmaceuticals
The main advantage of trading using opposite Unity Biotechnology and Recursion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unity Biotechnology position performs unexpectedly, Recursion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Recursion Pharmaceuticals will offset losses from the drop in Recursion Pharmaceuticals' long position.| Unity Biotechnology vs. Eliem Therapeutics | Unity Biotechnology vs. HCW Biologics | Unity Biotechnology vs. Scpharmaceuticals | Unity Biotechnology vs. Milestone Pharmaceuticals |
| Recursion Pharmaceuticals vs. Eliem Therapeutics | Recursion Pharmaceuticals vs. HCW Biologics | Recursion Pharmaceuticals vs. Scpharmaceuticals | Recursion Pharmaceuticals vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |